Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
General Insurance
Personal Lines
Return to: IBR Home | General Insurance | Personal Lines

FCA seeks feedback on consumer access to insurance

Published 21 June 2017

The Financial Conduct Authority (FCA) is asking for views and evidence of the challenges faced by companies in offering travel insurance for consumers who have, or have had, cancer, and the challenges faced by these consumers in accessing insurance.

The paper is also looking at the reasons for pricing differences in premiums quoted.

This paper looks more broadly at access issues related to insurance but specifically seeks views on how consumers with cancer or those in recovery can access the travel insurance market.

This is the FCA’s next step to address issues highlighted in the Occasional Paper on ‘Access to Financial Services in the UK’, published last year. This focused on problems consumers can face when trying to find insurance that meets their needs.

Christopher Woolard, Executive Director of Strategy and Competition at the FCA, said:

“Being able to access financial services is critical for people to fully participate in society. We hope that this will encourage discussion on access issues to examine the challenges for firms and consumers.”

“Given our previous findings in this area, we see this as a critical time to fully explore these issues and consider potential solutions.”

The FCA is seeking input on:

  • The challenges for firms in providing travel insurance for consumers who have, or have had, cancer.
  • The challenges consumers face when they have, or have had, cancer in finding suitable travel insurance.
  • Examples of innovative practices in the current market.
  • Any barriers that firms face in addressing existing challenges or that prevent innovation.
  • Potential improvements that could result in better consumer outcomes.

We want to understand how consumer outcomes can be improved in this area, including through innovation. The findings should read across to many other pre-existing medical conditions and insurance products.

Source: Company Press Release